chr6-25845472-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001098486.2(SLC17A3):c.1407C>T(p.Ala469=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 1,613,942 control chromosomes in the GnomAD database, including 60 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0016 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 55 hom. )
Consequence
SLC17A3
NM_001098486.2 synonymous
NM_001098486.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.466
Genes affected
SLC17A3 (HGNC:10931): (solute carrier family 17 member 3) The protein encoded by this gene is a voltage-driven transporter that excretes intracellular urate and organic anions from the blood into renal tubule cells. Two transcript variants encoding different isoforms have been found for this gene. The longer isoform is a plasma membrane protein with transporter activity while the shorter isoform localizes to the endoplasmic reticulum. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 6-25845472-G-A is Benign according to our data. Variant chr6-25845472-G-A is described in ClinVar as [Benign]. Clinvar id is 3044906.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.466 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00164 (249/152198) while in subpopulation EAS AF= 0.0268 (139/5182). AF 95% confidence interval is 0.0232. There are 5 homozygotes in gnomad4. There are 167 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC17A3 | NM_001098486.2 | c.1407C>T | p.Ala469= | synonymous_variant | 12/13 | ENST00000397060.8 | |
LOC124901285 | XR_007059518.1 | n.379+8940G>A | intron_variant, non_coding_transcript_variant | ||||
SLC17A3 | NM_006632.4 | c.1173C>T | p.Ala391= | synonymous_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC17A3 | ENST00000397060.8 | c.1407C>T | p.Ala469= | synonymous_variant | 12/13 | 2 | NM_001098486.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00165 AC: 251AN: 152080Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
251
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00541 AC: 1359AN: 251312Hom.: 29 AF XY: 0.00618 AC XY: 840AN XY: 135814
GnomAD3 exomes
AF:
AC:
1359
AN:
251312
Hom.:
AF XY:
AC XY:
840
AN XY:
135814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00172 AC: 2516AN: 1461744Hom.: 55 Cov.: 31 AF XY: 0.00226 AC XY: 1643AN XY: 727168
GnomAD4 exome
AF:
AC:
2516
AN:
1461744
Hom.:
Cov.:
31
AF XY:
AC XY:
1643
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00164 AC: 249AN: 152198Hom.: 5 Cov.: 32 AF XY: 0.00224 AC XY: 167AN XY: 74410
GnomAD4 genome
AF:
AC:
249
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
167
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
60
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC17A3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at